In a mouse model, blocking the LRRC33/TGF-β1 pathway resulted in a reduction in myeloid suppressor cells in the immunological microenvironment and enhanced the activity of CD8+ T and NK cells and the polarization of macrophages toward M1, thereby slowing tumor growth and metastasis [76]. Here, TGFB1 is linked to neoplasm.